Solesta fecal incontinence gel gets federal approval

Share this content:

Oceana Therapeutics has received Food and Drug Administration marketing approval for its Solesta injectable gel, the company announced. The product is intended to address fecal incontinence in patients for whom a change in diet, fiber therapy or anti-motility medication has not helped.